Allogeneic Transplantation for Advanced AML: The Value of Complete Remission

BACKGROUND: Patients with AML without complete remission (CR) or in first relapse (relapse1) can have extended leukemia control and survival following allogeneic hematopoietic cell transplantation (HCT). Transplantation in relapse1 or primary induction failure (PIF) versus treatment to achieve CR2 a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Weisdorf, Daniel, Millard, Heather R., Horowitz, Mary M., Hyare, Parvinder S., Champlin, Richard, Ho, Vincent, Mielcarek, Marco, Rezvani, Andrew, Stockerl-Goldstein, Keith, Khoury, Hanna J., De Lima, Marcos, Saber, Wael, Sandmaier, Brenda, Zhang, Mei Jie, Eapen, Mary
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445001/
https://ncbi.nlm.nih.gov/pubmed/28117884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30536
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados